Ratings by TD Cowen (Phil Nadeau)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/25/2026 | Century Therapeutics | IPSC | New Coverage | Buy (N/A) |
2.13 (2.56) |
20.19% | Details | |
| 2/12/2026 | XOMA, Ltd. | XOMA | New Coverage | Hold (N/A) |
23.27 (25.98) |
11.65% | Details | |
| 2/9/2026 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2026 | Rhythm Pharmaceuticals | RYTM | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2025 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 12/11/2025 | Rhythm Pharmaceuticals | RYTM | Maintain | Buy (N/A) |
|
Details | ||
| 12/10/2025 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 12/9/2025 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (N/A) |
|
Details | ||
| 12/5/2025 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2025 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2025 | Neurocrine Bio. | NBIX | Maintain | (N/A) |
|
Details | ||
| 8/21/2025 | Dynavax Technologies | DVAX | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2025 | Rhythm Pharmaceuticals | RYTM | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2025 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2025 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2025 | Aura Biosciences | AURA | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2025 | Moonlake Immunotherapeutics | MLTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2025 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2025 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2025 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/21/2024 | Kura Oncology | KURA | Maintain | Buy (N/A) |
|
Details | ||
| 11/20/2024 | Vir Biotechnology | VIR | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2024 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2024 | Syros Pharmaceuticals | SYRS | Downgrade | Hold (Buy) |
3.23 (0.12) |
-96.28% | Details | |
| 11/6/2024 | Rhythm Pharmaceuticals | RYTM | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2024 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 10/23/2024 | Annexon Biosciences | ANNX | Maintain | Buy (N/A) |
|
Details | ||
| 10/18/2024 | Aura Biosciences | AURA | Maintain | Buy (N/A) |
|
Details | ||
| 10/1/2024 | Kezer Life Sciences | KZR | Maintain | Buy (N/A) |
|
Details | ||
| 9/24/2024 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 9/12/2024 | Aura Biosciences | AURA | Maintain | Buy (N/A) |
|
Details | ||
| 9/5/2024 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 8/28/2024 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2024 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2024 | Kezer Life Sciences | KZR | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2024 | Syros Pharmaceuticals | SYRS | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2024 | Annexon Biosciences | ANNX | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2024 | Annexon Biosciences | ANNX | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2024 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 7/23/2024 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2024 | Syros Pharmaceuticals | SYRS | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2024 | Annexon Biosciences | ANNX | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2024 | Galapagos NV | GLPG | Maintain | Buy (N/A) |
|
Details | ||
| 5/14/2024 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2024 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2024 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/4/2024 | Rhythm Pharmaceuticals | RYTM | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2023 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2023 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2023 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2023 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/1/2023 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 7/17/2023 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 6/28/2023 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/2/2023 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2023 | Graphite Bio Inc | GRPH | Downgrade | Hold (Buy) |
2.20 (3.18) |
44.55% | Details | |
| 2/16/2023 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2023 | Frequency Therapeutics | FREQ | Downgrade | Hold (Buy) |
3.93 (0.30) |
-92.37% | Details | |
| 11/18/2022 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2022 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 10/26/2022 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 10/24/2022 | PhaseBio Pharmaceuticals Inc. | PHAS | Downgrade | Hold (Buy) |
0.20 (0.07) |
-65% | Details | |
| 10/24/2022 | Tricida | TCDA | Downgrade | Hold (Buy) |
10.88 (0.11) |
-98.99% | Details | |
| 8/9/2022 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2022 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/21/2022 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 5/2/2022 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/4/2022 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 1/24/2022 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/10/2022 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 12/8/2021 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 11/23/2021 | Aura Biosciences | AURA | New Coverage | Buy (N/A) |
19.63 (5.60) |
-71.47% | Details | |
| 11/17/2021 | Vir Biotechnology | VIR | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2021 | Dynavax Technologies | DVAX | Maintain | Buy (N/A) |
|
Details | ||
| 10/20/2021 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 9/22/2021 | Dynavax Technologies | DVAX | Maintain | Buy (N/A) |
|
Details | ||
| 8/24/2021 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 8/23/2021 | Icosavax Inc. | ICVX | New Coverage | Buy (N/A) |
34.60 (15.31) |
-55.75% | Details | |
| 7/20/2021 | Graphite Bio Inc | GRPH | New Coverage | Buy (N/A) |
27.54 (3.18) |
-88.45% | Details | |
| 7/13/2021 | Ambrx Biopharma | AMAM | New Coverage | Buy (N/A) |
21.30 (28.00) |
31.46% | Details | |
| 7/1/2021 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 6/7/2021 | Biogen | BIIB | Upgrade | Buy (Hold) |
286.14 (184.87) |
-35.39% | Details | |
| 4/29/2021 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 4/22/2021 | Biogen | BIIB | Maintain | Hold (N/A) |
|
Details | ||
| 2/26/2021 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 2/16/2021 | GW Pharma | GWPH | Maintain | Buy (N/A) |
|
Details | ||
| 2/4/2021 | Alexion Pharmaceuticals | ALXN | Maintain | Buy (N/A) |
|
Details | ||
| 1/13/2021 | Acorda Therapeutics, Inc. | ACOR | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2020 | Biogen | BIIB | Downgrade | Hold (Buy) |
324.77 (286.14) |
-11.89% | Details | |
| 11/4/2020 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2020 | GW Pharma | GWPH | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2020 | Kronos Bio Inc. | KRON | New Coverage | Buy (N/A) |
26.93 (0.88) |
-96.73% | Details | |
| 10/30/2020 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/18/2020 | Annexon Biosciences | ANNX | New Coverage | Buy (N/A) |
26.55 (5.16) |
-80.56% | Details | |
| 8/6/2020 | Immunomedics | IMMU | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2020 | Tricida | TCDA | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2020 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/23/2020 | Dynavax Technologies | DVAX | Maintain | Buy (N/A) |
|
Details | ||
| 7/21/2020 | Akouos | AKUS | New Coverage | Buy (N/A) |
21.17 (13.29) |
-37.22% | Details | |
| 7/16/2020 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/16/2020 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 7/8/2020 | Dynavax Technologies | DVAX | Maintain | Buy (N/A) |
|
Details | ||
| 7/6/2020 | Immunomedics | IMMU | Maintain | Buy (N/A) |
|
Details | ||
| 6/19/2020 | Dynavax Technologies | DVAX | Maintain | Buy (Buy) |
|
Details | ||
| 6/18/2020 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 4/23/2020 | Immunomedics | IMMU | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2020 | Immunomedics | IMMU | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2020 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2020 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 1/31/2020 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/24/2020 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/16/2020 | Acorda Therapeutics, Inc. | ACOR | Maintain | Buy (N/A) |
|
Details | ||
| 1/14/2020 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 12/12/2019 | Alexion Pharmaceuticals | ALXN | Maintain | Buy (N/A) |
|
Details | ||
| 11/19/2019 | Cabaletta Bio Inc. | CABA | New Coverage | Buy (N/A) |
13.79 (3.17) |
-77.01% | Details | |
| 11/13/2019 | La Jolla Pharma | LJPC | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2019 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2019 | Vir Biotechnology | VIR | New Coverage | Buy (N/A) |
15.75 (9.55) |
-39.37% | Details | |
| 10/28/2019 | Frequency Therapeutics | FREQ | New Coverage | Buy (N/A) |
14.05 (3.93) |
-72.03% | Details | |
| 10/23/2019 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 7/15/2019 | Atreca Inc. | BCEL | New Coverage | Buy (N/A) |
16.74 (0.09) |
-99.46% | Details | |
| 5/7/2019 | La Jolla Pharma | LJPC | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2019 | GW Pharma | GWPH | Maintain | Buy (N/A) |
|
Details | ||
| 3/21/2019 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2019 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2019 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/22/2019 | Editas Medicine | EDIT | Maintain | Buy (N/A) |
|
Details | ||
| 11/30/2018 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/12/2018 | PhaseBio Pharmaceuticals Inc. | PHAS | New Coverage | Buy (N/A) |
5.01 (0.07) |
-98.6% | Details | |
| 11/8/2018 | Portola Pharmaceuticals | PTLA | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2018 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2018 | Allogene | ALLO | New Coverage | Buy (N/A) |
26.95 (15.73) |
-41.63% | Details | |
| 10/25/2018 | La Jolla Pharma | LJPC | Maintain | Buy (N/A) |
|
Details | ||
| 9/27/2018 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details |
